Guru Ownership Trend
Guru Analysis for Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.49 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $937,214.93 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 138.2%. Conversely, Steven Cohen reduced exposure by 17.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Aura Biosciences, Inc. (AURA)
Major holders include Renaissance Technologies (RenTech) ($1.24 M), Cliff Asness ($780,213), Ken Fisher ($592,906). According to the latest reported data, 4 tracked investment managers collectively hold approximately 385,461 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $937,214.93, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited AURA. The total reported sell value was $27,292.31.
Yes, 0 managers opened new positions in AURA, and 2 increased their existing holdings. The total reported buy value was $964,507.24.